Vanda Pharmaceuticals Inc. v. Roxane Laboratories Inc.

Application Number	Patent Number	External Links
-	US8586610	Espacenet Google Patents
-	USRE39198	Espacenet Google Patents

COMPLAINT FOR PATENT INFRINGEMENT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1414594.) - filed by Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Aventisub II Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 11/26/2013)

2013-11-25

1

Download

COMPLAINT FOR PATENT INFRINGEMENT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1414594.) - filed by Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Aventisub II Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 11/26/2013)

2013-11-25

2

View

COMPLAINT FOR PATENT INFRINGEMENT filed against Roxane Laboratories Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1414594.) - filed by Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Aventisub II Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 11/26/2013)

2013-11-25

2

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 11/26/2013)

2013-11-25

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/17/13. Date of Expiration of Patent: 11/15/16.Thirty Month Stay Deadline: 11/9/2016. (cla, ) (Entered: 11/26/2013)

2013-11-25

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 39,198E;. (cla, ) (Entered: 11/26/2013)

2013-11-25

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (cla, ) (Entered: 11/26/2013)

2013-11-25

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (cla, ) (Entered: 11/26/2013)

2013-11-25

1

View

Disclosure Statement pursuant to Rule 7.1 filed by Aventisub II Inc. identifying Other Affiliate Sanofi for Aventisub II Inc.. (cla, ) (Entered: 11/26/2013)

2013-11-25

1

View

Summons Issued with Magistrate Consent Notice attached as to Roxane Laboratories Inc. on 11/26/2013. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (cla, )

2013-11-26

1

No Actions

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)

2013-11-27

1

No Actions

DECLARATION of Mailing (as to service on Defendant Roxane Laboratories, Inc.) by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 12/02/2013)

2013-12-02

1

View

STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to January 3, 2014 - filed by Roxane Laboratories Inc.. (Horwitz, Richard) (Entered: 12/18/2013)

2013-12-18

1

View

SO ORDERED, re 9 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to January 3, 2014 filed by Roxane Laboratories Inc. Set/Reset Answer Deadlines: Roxane Laboratories Inc. answer due 1/3/2014. Signed by Chief Judge Gregory M. Sleet on 12/18/13. (mmm)

2013-12-18

1

No Actions

ANSWER to 1 Complaint,, COUNTERCLAIM against Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation by Roxane Laboratories Inc..(Moore, David) (Entered: 12/20/2013)

2013-12-20

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 12/20/2013)

2013-12-20

1

View

ANSWER to 10 Answer to Complaint, Counterclaim Plaintiffs' Reply to Defendants' Counterclaim by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/10/2014)

2014-01-10

1

View

MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Emily C. Melvin, and Michael R. Seringhaus of Latham & Watkins LLP - filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 02/11/2014)

2014-02-11

1

View

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Emily C. Melvin, and Michael R. Seringhaus of Latham & Watkins LLP filed by Roxane Laboratories Inc. Ordered by Chief Judge Gregory M. Sleet on 2/11/14. (mmm)

2014-02-11

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Certification for Nicholas N. Kallas)(Silver, Daniel) (Entered: 02/12/2014)

2014-02-12

1

View

Pro Hac Vice Attorney Emily C. Melvin,Kenneth G. Schuler,Michael R. Seringhaus for Roxane Laboratories Inc. added for electronic noticing. (dmp, )

2014-02-12

1

No Actions

SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Chief Judge Gregory M. Sleet on 2/18/2014. (asw)

2014-02-18

1

No Actions

Pro Hac Vice Attorney Nicholas Kallas for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

2014-02-20

1

No Actions

ORAL ORDER SCHEDULING A RULE 16.2b SCHEDULING TELECONFERENCE: A Rule 16.2b Scheduling Teleconference has been set in this matter for Monday, March 31, 2014, at 3:00 PM with the Honorable Gregory M. Sleet. The parties shall file a Joint Status Report by the close of business on Tuesday, March 25, 2014. Counsel for plaintiff is directed to initiate the call and contact chambers at (302) 573-4559 once all parties are on the line. Ordered by Chief Judge Sleet on 3/6/2014. (ctd)

2014-03-06

1

No Actions

Joint STATUS REPORT by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 03/25/2014)

2014-03-25

1

View

PROPOSED ORDER Proposed Scheduling Order re 15 Status Report by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 03/25/2014)

2014-03-25

1

View

Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 3/31/2014. Markman Hearing (3 hrs) set for 3/31/2015 at 9:30 AM., Pretrial Order due by 11/13/2015., Pretrial Conference (by phone) set for 12/15/2015 at 10:00 AM., 4-day Bench Trial set for 1/11/2016 at 9:00 AM. Refer this case to the Magistrate for ADR. Plaintiff's counsel shall file a proposed scheduling order by 4/7/2014. (Court Reporter: Kevin Maurer.) (asw)

2014-03-31

1

No Actions

Official Transcript of Teleconference held on 03 31 14 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 4/28/2014. Redacted Transcript Deadline set for 5/8/2014. Release of Transcript Restriction set for 7/7/2014. (kjm) (Entered: 04/07/2014)

2014-04-07

1

View

Joint PROPOSED ORDER (Proposed Scheduling Order) by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/07/2014)

2014-04-07

1

View

ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 5/5/2014 at 10:00 AM EASTERN TIME before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 4/10/14. (cak) (Entered: 04/10/2014)

2014-04-10

1

View

CASE REFERRED to Judge Thynge for Mediation. (cak)

2014-04-10

1

No Actions

SO ORDERED, re 18 Proposed Order filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, ORDER, Setting Scheduling Order Deadlines Case referred to the Magistrate Judge for the purpose of exploring ADR. ( Claim Construction Opening Brief due by 1/23/2015., A Pretrial Conference is set for 12/15/2015 at 10:00 AM before Judge Gregory M. Sleet., Amended Pleadings due by 2/13/2015., Fact Discovery due by 4/3/2015., Completion of Expert Discovery due by 8/28/2015., Joinder of Parties due by 2/13/2015., A Markman Hearing (3 hrs) is set for 3/31/2015 at 09:30 AM in Courtroom 4A before Judge Gregory M. Sleet., Proposed Pretrial Order due by 11/13/2015., A 4-day Bench Trial is set for 1/11/2016 at 09:00 AM in Courtroom 4A before Judge Gregory M. Sleet.). Ordered by Chief Judge Gregory M. Sleet on 4/10/2014. (asw)

2014-04-10

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/21/2014)

2014-04-21

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Roxane Laboratories Inc..(Horwitz, Richard) (Entered: 04/21/2014)

2014-04-21

1

View

Joint STIPULATION TO EXTEND TIME for Plaintiffs to File the Joint Proposed Protective Order to Monday, May 5, 2014 (from Monday, April 21, 2014) - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/21/2014)

2014-04-21

1

View

SO ORDERED, re 22 Joint STIPULATION TO EXTEND TIME for Plaintiffs to File the Joint Proposed Protective Order to Monday, May 5, 2014 (from Monday, April 21, 2014) filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Chief Judge Gregory M. Sleet on 4/28/2014. (asw)

2014-04-28

1

No Actions

Joint MOTION for Protective Order [Proposed] Stipulated Protective Order - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/05/2014)

2014-05-05

1

View

SO ORDERED, re 23 Joint MOTION for Protective Order [Proposed] Stipulated Protective Order filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Chief Judge Gregory M. Sleet on 5/6/2014. (asw)

2014-05-06

1

No Actions

ORDER Setting Mediation Conferences: A Telephone Conference is set for 9/30/2014 at 09:00 AM EASTERN TIME before Judge Mary Pat Thynge. Defense counsel shall initiate the teleconference call. A Mediation Conference is TENTATIVELY set for 11/4/2014 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 5/8/14. (cak) (Entered: 05/07/2014)

2014-05-07

1

View

NOTICE of CHANGE OF FIRM ADDRESS by Roxane Laboratories Inc. (Moore, David) (Entered: 05/12/2014)

2014-05-12

1

View

NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Delaware Default Standard Paragraphs 3 and 5 filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/16/2014)

2014-05-16

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Disclosures Pursuant to Delaware Default Standard for Discovery filed by Roxane Laboratories Inc..(Horwitz, Richard) (Entered: 05/16/2014)

2014-05-16

1

View

NOTICE OF SERVICE of Roxane's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-73) filed by Roxane Laboratories Inc..(Struble, Erich) (Entered: 06/04/2014)

2014-06-04

1

View

NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests to Roxane for the Production of Documents and Things; and (2) Plaintiffs' First Set of Interrogatories to Roxane filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/05/2014)

2014-06-05

1

View

NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions to Roxane filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/09/2014)

2014-06-09

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Amended Disclosures Pursuant to Delaware Default Standard for Discovery filed by Roxane Laboratories Inc..(Struble, Erich) (Entered: 06/13/2014)

2014-06-13

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Initial Invalidity Contentions filed by Roxane Laboratories Inc..(Horwitz, Richard) (Entered: 07/03/2014)

2014-07-03

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Objections and Responses to Novartis's First Set of Requests for the Production of Documents and Things and Defendant Roxane Laboratories, Inc.'s Objections and Responses to Novartis's First Set of Interrogatories to Roxane [Confidential] filed by Roxane Laboratories Inc..(Struble, Erich) (Entered: 07/08/2014)

2014-07-08

1

View

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Roxane's First Set of Requests for Production filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/10/2014)

2014-07-10

1

View

NOTICE OF SERVICE of Roxane's First Set of Interrogatories to Plaintiffs (Nos. 1-6) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 08/13/2014)

2014-08-13

1

View

MOTION for Pro Hac Vice Appearance of Attorney Christina Schwarz - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification of Christina Schwarz)(Silver, Daniel) (Entered: 08/28/2014)

2014-08-28

1

View

SO ORDERED, re 36 MOTION for Pro Hac Vice Appearance of Attorney Christina Schwarz filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Judge Gregory M. Sleet on 8/28/2014. (asw)

2014-08-28

1

No Actions

Pro Hac Vice Attorney Christina Schwarz for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)

2014-08-29

1

No Actions

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Roxane's First Set of Interrogatories (Nos. 1-6) filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/15/2014)

2014-09-15

1

View

ORAL ORDER: A teleconference has been scheduled for 2/3/15 at 10:00 AM EASTERN TIME with Judge Thynge to discuss the status of the case and mediation. The mediation tentatively set for 11/4/14 at 10:00 AM with Judge Thynge has been rescheduled to 3/19/15 at 10:00 AM. Submissions of the parties shall now be due on or about 2/27/15. All other provisions of the Court's 5/8/14 Order remain in full force and effect. Ordered by Judge Mary Pat Thynge on 9/30/14. (cak) (Entered: 09/30/2014)

2014-09-30

1

View

MOTION for Pro Hac Vice Appearance of Attorney Timothy J. O'Brien - filed by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 10/03/2014)

2014-10-03

1

View

SO ORDERED, re 39 MOTION for Pro Hac Vice Appearance of Attorney Timothy J. O'Brien filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 10/6/2014. (asw)

2014-10-06

1

No Actions

Pro Hac Vice Attorney Timothy J. O'Brien for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

2014-10-07

1

No Actions

STIPULATION and [Proposed] Order Amending Case Scheduling Order to Remove Claim Construction Deadlines and Hearing by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 10/16/2014)

2014-10-16

1

View

SO ORDERED - re 40 Stipulation. The claim construction deadlines are terminated and the Markman Hearing set for 3/31/2015 at 9:30 AM is CANCELED. Signed by Judge Gregory M. Sleet on 10/17/2014. (mdb) (Entered: 10/17/2014)

2014-10-17

1

View

(WITHDRAWN) MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Roxane Laboratories Inc.. (Palapura, Bindu) Modified on 10/31/2014 (mdb). (Entered: 10/21/2014)

2014-10-21

1

View

(WITHDRAWN) OPENING BRIEF in Support re 42 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Roxane Laboratories Inc..Answering Brief/Response due date per Local Rules is 11/7/2014. (Attachments: # 1 Exhibit A-B)(Palapura, Bindu) Modified on 10/31/2014 (mdb). (Entered: 10/21/2014)

2014-10-21

1

View

NOTICE of Withdrawal of Defendant's Motion to Dismiss and Supporting Brief by Roxane Laboratories Inc. re 42 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter, 43 Opening Brief in Support, (Palapura, Bindu) (Entered: 10/30/2014)

2014-10-30

1

View

MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 10/30/2014)

2014-10-30

1

View

OPENING BRIEF in Support re 45 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Roxane Laboratories Inc..Answering Brief/Response due date per Local Rules is 11/17/2014. (Attachments: # 1 Exhibit A-B)(Palapura, Bindu) (Entered: 10/30/2014)

2014-10-30

1

View

MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 11/17/2014)

2014-11-17

1

View

BRIEF (Combined Opening and Answering) Plaintiffs' Combined Brief In Support of Plaintiffs' Motion Under Fed. R. Civ. P. 25 (c) to Amend the Caption and Plaintiffs' Opposition to Defendant's Motion to Dismiss for Lack of Jurisdiction re 47 MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION, 45 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.Answering Brief/Response due date per Local Rules is 12/4/2014. Reply Brief due date per Local Rules is 11/28/2014. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Silver, Daniel) (Entered: 11/17/2014)

2014-11-17

1

View

DECLARATION re 48 Brief (Combined Opening and Answering),, Declaration of Andrea Q. Ryan by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Appendix A - E)(Silver, Daniel) (Entered: 11/17/2014)

2014-11-17

1

View

STATEMENT re 47 MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION Rule 7.1.1 Certification by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 11/18/2014)

2014-11-18

1

View

STIPULATION to Extend Certain Briefing Deadlines by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 11/20/2014)

2014-11-20

1

View

SO ORDERED - re 51 Stipulation to Extend Certain Briefing Deadlines filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 11/25/2014. (mdb)

2014-11-25

1

No Actions

BRIEF (Combined Answering and Reply) re 47 MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION, 45 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Roxane Laboratories Inc..Reply Brief due date per Local Rules is 12/22/2014. (Moore, David) (Entered: 12/11/2014)

2014-12-11

1

View

REPLY BRIEF re 47 MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/09/2015)

2015-01-09

1

View

NOTICE of of Issuance of Subpoenas by Roxane Laboratories Inc. (Attachments: # 1 Exhibit 1-2, # 2 Exhibit 3, # 3 Exhibit 4, # 4 Exhibit 5-6)(Palapura, Bindu) (Entered: 01/27/2015)

2015-01-27

1

View

NOTICE of Issuance of Subpoena and Deposition upon Edward J. Glamkowski by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 02/02/2015)

2015-02-02

1

View

NOTICE of Issuance of Subpoena and Deposition upon Kenneth J. Bordeau by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 02/02/2015)

2015-02-02

1

View

NOTICE of Issuance of Subpoena and Deposition upon Yulin Chiang by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 02/02/2015)

2015-02-02

1

View

NOTICE of Issuance of Subpoena and Deposition upon Joseph T. Strupczewski by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 02/02/2015)

2015-02-02

1

View

NOTICE of Issuance of Amended Subpoena upon Kenneth J. Bordeau by Roxane Laboratories Inc. (Attachments: # 1 part 2)(Palapura, Bindu) (Entered: 02/02/2015)

2015-02-02

1

View

NOTICE of Issuance of Amended Subpoenas upon Kenneth J. Bordeau, Yulin Chiang, Edward J. Glamkowski, and Joseph T. Strupczewski by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 02/03/2015)

2015-02-03

1

View

ORAL ORDER: The mediation scheduled for 3/19/15 at 10:00 AM with Judge Thynge are cancelled. Therefore, there shall be no submission of mediation statements. Ordered by Judge Mary Pat Thynge on 2/4/15. (cak) (Entered: 02/04/2015)

2015-02-04

1

View

ORDER Setting Mediation Conferences: A Telephone Conference is set for 3/19/2015 at 10:00 AM EASTERN TIME before Judge Mary Pat Thynge. A Mediation Conference is set for 6/2/2015 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/9/15. (cak) (Entered: 02/09/2015)

2015-02-09

1

View

ORDER Setting Mediation Conferences: A Telephone Conference is set for 3/19/2015 at 10:00 AM EASTERN TIME before Judge Mary Pat Thynge. A Mediation Conference is set for 6/2/2015 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 2/9/15. (cak) (Entered: 02/09/2015)

2015-02-09

1

View

NOTICE OF SERVICE of Roxane's Second Set of Interrogatories (Nos. 7-9) and Roxane's Second Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 74-79) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 02/25/2015)

2015-02-25

1

View

ORAL ORDER: The teleconference scheduled for 3/19/15 at 10:00 AM Eastern Time with Judge Thynge has been rescheduled to 3/24/15 at 1:00 PM Eastern Time. Counsel for Roxane shall initiate the teleconference call. Ordered by Judge Mary Pat Thynge on 3/18/15. (cak) (Entered: 03/18/2015)

2015-03-18

1

View

NOTICE requesting Clerk to remove Nicholas N. Kallas & Christina Schwarz as co-counsel.. (Silver, Daniel) (Entered: 03/19/2015)

2015-03-19

1

View

Consent MOTION to Substitute Party: Vanda Pharmaceuticals Inc. to replace Novartis Pharmaceuticals Corporation and Novartis Pharma AG - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 03/19/2015)

2015-03-19

1

View

NOTICE OF SUBSTITUTION OF COUNSEL re Aventisub II Inc.: Entry of appearance of attorney Karen Jacobs. Attorney Daniel M. Silver of McCarter & English, LLP terminated. (Jacobs, Karen) (Entered: 03/19/2015)

2015-03-19

1

View

MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis and Josephine Young of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Aventisub II Inc.. (Jacobs, Karen) (Entered: 03/26/2015)

2015-03-26

1

View

SO ORDERED - re 66 Consent MOTION to Substitute Party: Vanda Pharmaceuticals Inc. to replace Novartis Pharmaceuticals Corporation and Novartis Pharma AG. Signed by Judge Gregory M. Sleet on 3/25/2015. (mdb) (Entered: 03/26/2015)

2015-03-26

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Objections & Responses to Roxane's Second Set of Interrogatories (Nos. 7-9) and (2) Plaintiffs' Objections & Responses to Roxane's Second Set of Requests for Production (Nos. 74-79) filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Jacobs, Karen) (Entered: 03/27/2015)

2015-03-27

1

View

SO ORDERED - re 68 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis and Josephine Young of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Aventisub II Inc. Ordered by Judge Gregory M. Sleet on 3/27/2015. (mdb)

2015-03-27

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis and Josephine Young of Paul, Weiss, Rifkind, Wharton & Garrison LLP - filed by Aventisub II Inc., Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (Entered: 03/31/2015)

2015-03-31

1

View

Pro Hac Vice Attorney Nicholas Groombridge for Aventisub II Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)

2015-04-01

1

No Actions

Pro Hac Vice Attorney Eric A. Stone for Aventisub II Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)

2015-04-01

1

No Actions

Pro Hac Vice Attorney Kira A. Davis for Aventisub II Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)

2015-04-01

1

No Actions

Pro Hac Vice Attorney Josephine Young for Aventisub II Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)

2015-04-01

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Telephone Scheduling Conference held on 4/1/2015. CA 14-757-GMS will be consolidated for all purposed with CA No. 13-1973-GMS upon the filing of a Joint Motion to Consolidate by the parties. Initial Disclosures due by 4/10/2015; A Markman Hearing (3 hours) is set for 9/2/2015 at 2:00 PM in Courtroom 4A; Proposed Final Pretrial Order due by the close of business on 1/29/2016; A Pretrial Conference (via telephone) is set for 2/17/2016 at 10:00 AM; A 4-day Bench Trial is set for 2/29/2016 at 9:00 AM in Courtroom 4A; The parties may adjust the deadlines for claim construction briefing and discovery, and include the proposed dates in the propsed case management order. Plaintiff shall file the proposed case management order by 4/8/2015. (Court Reporter Kevin Maurer.) (mdb)

2015-04-01

1

No Actions

SO ORDERED - re 71 MOTION for Pro Hac Vice Appearance of Attorney Nicholas Groombridge, Eric Alan Stone, Kira A. Davis and Josephine Young of Paul, Weiss, Rifkind, Wharton & Garrison LLP filed by Aventisub II Inc., Vanda Pharmaceuticals Inc. Ordered by Judge Gregory M. Sleet on 4/1/2015. (mdb)

2015-04-01

1

No Actions

NOTICE OF SERVICE of Plaintiffs' First Supplemental Objections And Responses To Roxane's Interrogatory Nos. 7 And 8 filed by Vanda Pharmaceuticals Inc..(Blumenfeld, Jack) (Entered: 04/10/2015)

2015-04-10

1

View

Remark - Cases have been consolidated for all purposes pursuant the oral order entered on April 13, 2015. The parties are instructed to file all future filings only in Lead C.A. No. 13-1973 GMS. Associated Cases: 1:13-cv-01973-GMS, 1:14-cv-00757-GMS(mdb)

2015-04-13

1

No Actions

SO ORDERED - re (24 in 1:14-cv-00757-GMS) Proposed Scheduling Order. Pursuant to the April 1, 2015 teleconference, THESE CASES ARE CONSOLIDATED FOR ALL PURPOSES. ALL FUTURE FILINGS SHALL BE MADE ONLY IN LEAD C.A. NO. 13-1973 GMS. Claim Construction: Opening Brief due by 7/1/2015, Answering Brief due by 7/31/2015; A Markman Hearing (3 hours) is set for 9/2/2015 at 2:00 PM in Courtroom 4A; Fact Discovery completed by 8/14/2015; Expert Discovery: Opening Reports due by 10/19/2015, Rebuttal Reports due by 11/16/2015, Reply Reports due by 12/7/2015, Expert Discovery completed by 1/11/2016; Proposed Final Pretrial Order due by 1/29/2016; A Final Pretrial Conference (via telephone) is set for 2/17/2016 at 10:00 AM; A 4-day Bench Trial is set for 2/29/2016 at 9:00 AM in Courtroom 4A; Case referred to the Magistrate Judge for the purpose of exploring ADR.). Ordered by Judge Gregory M. Sleet on 4/13/2015. (mdb)

2015-04-13

1

No Actions

NOTICE OF SERVICE of Defendant's First Set of Interrogatories to Plaintiffs (Nos. 1-7) and Defendant's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-54) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 04/23/2015)

2015-04-23

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Initial Invalidity Contentions filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 05/05/2015)

2015-05-05

1

View

NOTICE OF SERVICE of (1) Vanda's First Set of Interrogatories to Roxane (Nos. 1-7); and (2) Vanda's First Set of Requests for Production of Documents and Things to Roxane (Nos. 1-75) filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 05/15/2015)

2015-05-15

1

View

NOTICE OF SERVICE of Roxane's Proposed Claim Terms for Construction filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 05/18/2015)

2015-05-18

1

View

NOTICE OF SERVICE of Roxane's Second Set of Interrogatories to Plaintiffs (No. 8) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 05/19/2015)

2015-05-19

1

View

NOTICE of Issuance of Amended Subpoena upon Kenneth J. Bordeau by Roxane Laboratories Inc. (Moore, David) (Entered: 05/22/2015)

2015-05-22

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Roxane's First Set of Interrogatories (Nos. 1-7); and (2) Vanda Pharmaceuticals Inc.s' Objections and Responses to Defendant's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-54) filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 05/29/2015)

2015-05-29

1

View

NOTICE of Issuance of Subpoena upon Hoffman Warnick LLC by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 05/29/2015)

2015-05-29

1

View

NOTICE of Issuance of Second Amended Subpoena upon Kenneth J. Bordeau by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 05/29/2015)

2015-05-29

1

View

NOTICE OF SERVICE of Roxane's Proposed Claim Terms for Construction filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 06/02/2015)

2015-06-02

1

View

NOTICE to Take Deposition of Novartis Pharmaceuticals Corporation, Novartis Pharma AG, and Aventisub II Inc. on July 9, 2015 (Notice of 30(b)(6) Deposition) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 06/12/2015)

2015-06-12

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Objections and Responses to Vanda's First Set of Interrogatories to Roxane [Confidential]; and Defendant Roxane Laboratories, Inc.'s Objections and Responses to Vanda's First Set of Requests for Production of Documents and Things filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 06/16/2015)

2015-06-16

1

View

NOTICE of Issuance of Subpoena upon Hoffman Warnick LLC by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 06/17/2015)

2015-06-17

1

View

CLAIM Construction Chart by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 06/17/2015)

2015-06-17

1

View

NOTICE OF SERVICE of Hoffman Warnick LLC's Objections and Responses to Defendant's Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 06/18/2015)

2015-06-18

1

View

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Roxane's Second Set of Interrogatories (No. 8) filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 06/22/2015)

2015-06-22

1

View

CLAIM CONSTRUCTION OPENING BRIEF [Vanda Pharmaceuticals Inc.'s Opening Claim Construction Brief] filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 07/01/2015)

2015-07-01

1

View

DECLARATION re 89 Claim Construction Opening Brief [Declaration of Josephine Young in Support of Vanda's Opening Claim Construction Brief] by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation, Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit 1 through 6)(Townsend, Ethan) (Entered: 07/01/2015)

2015-07-01

1

View

CLAIM CONSTRUCTION OPENING BRIEF filed by Roxane Laboratories Inc.. (Attachments: # 1 Exhibit 1-6, # 2 Exhibit 7-11)(Palapura, Bindu) (Entered: 07/01/2015)

2015-07-01

1

View

NOTICE OF SERVICE of Aventisub's Responses and Objections to Defendant's Notice of Deposition Under Rule 30(b)(6) filed by Aventisub II Inc..(Townsend, Ethan) (Entered: 07/07/2015)

2015-07-07

1

View

NOTICE OF SERVICE of Vanda's Second Set of Interrogatories to Roxane (No. 8) filed by Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Roxane Laboratories, Inc. on August 3, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Jerry Andry on August 5, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Julie Economou on August 4, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Kim Ingram on August 6, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Randall S. Wilson on August 11, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Shehla Uraizee on August 7, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE to Take Deposition of Christopher Rohrs on August 10, 2015 filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/10/2015)

2015-07-10

1

View

NOTICE OF SERVICE of (1) Vanda's First Set of Requests for Admission to Roxane (Nos.1-4); and (2) Vanda's Third Set of Interrogatories to Roxane (Nos.9-10) filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/15/2015)

2015-07-15

1

View

NOTICE OF SERVICE of Roxane's Third Set of Requests for Production to Plaintiffs (Nos. 55-56) and Roxane's Third Set of Interrogatories to Plaintiffs (Nos. 9-13) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 07/15/2015)

2015-07-15

1

View

NOTICE OF SERVICE of Hoffman Warnick LLC's Objections and Responses to Defendant's Subpoena to Testify at a Deposition in a Civil Action filed by Aventisub II Inc., Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 07/20/2015)

2015-07-20

1

View

STIPULATION Amending Scheduling Order re fact discovery by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 07/20/2015)

2015-07-20

1

View

Set/Reset Scheduling Order Deadlines AND SO ORDERED

2015-07-21

1

No Actions

SO ORDERED - re 104 Stipulation to Amend Scheduling Order re Fact Discovery filed by Roxane Laboratories Inc. Set/Reset Scheduling Order Deadlines: ( Fact Discovery completed by 8/28/2015.) Ordered by Judge Gregory M. Sleet on 7/21/2015. (mdb)

2015-07-21

1

No Actions

ORDER - denying 45 Motion to Dismiss for Lack of Subject Jurisdiction ; granting 47 Motion to Amend the Caption. Signed by Judge Gregory M. Sleet on 7/24/2015. (mdb) (Entered: 07/24/2015)

2015-07-24

1

View

NOTICE OF SERVICE of Roxane's Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) (Confidential) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 07/27/2015)

2015-07-27

1

View

NOTICE to Take Deposition of Vanda Pharmaceuticals Inc. on August 24, 2015 filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 07/29/2015)

2015-07-29

1

View

NOTICE OF SERVICE of Defendant's Fourth Set Of Interrogatories To Plaintiffs (No. 14) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 07/29/2015)

2015-07-29

1

View

CLAIM CONSTRUCTION ANSWERING BRIEF [Vanda's Answering Claim Construction Brief] filed by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (Entered: 07/31/2015)

2015-07-31

1

View

DECLARATION re 109 Claim Construction Answering Brief [Declaration of Josephine Young in Support of Vanda's Answering Claim Construction Brief] by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Jacobs, Karen) (Entered: 07/31/2015)

2015-07-31

1

View

Joint APPENDIX re 109 Claim Construction Answering Brief [Joint Appendix of Intrinsic Evidence] by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Attachments: # 1 Appendix Part 2, # 2 Appendix Part 3, # 3 Appendix Part 4)(Jacobs, Karen) (Entered: 07/31/2015)

2015-07-31

1

View

[SEALED] CLAIM CONSTRUCTION ANSWERING BRIEF re 89 Claim Construction Opening Brief filed by Roxane Laboratories Inc.. (Attachments: # 1 Exhibit A-B, # 2 Exhibit C-F)(Palapura, Bindu) (Entered: 07/31/2015)

2015-07-31

1

View

NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Roxane's Interrogatory Nos. 1 and 5 filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 08/05/2015)

2015-08-05

1

View

REDACTED VERSION of 112 Claim Construction Answering Brief re 89 Claim Construction Opening Brief by Roxane Laboratories Inc.. (Attachments: # 1 Exhibit A-B, # 2 Exhibit C-F)(Palapura, Bindu) (Entered: 08/06/2015)

2015-08-06

1

View

NOTICE to Take Deposition of Paolo Baroldi on August 28, 2015 filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 08/10/2015)

2015-08-10

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Objections and Responses to Vanda's Second Set of Interrogatories to Roxane filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 08/11/2015)

2015-08-11

1

View

NOTICE OF SERVICE of Roxane's Objections and Responses to Vanda's First Set of Admission (Nos. 1-4) (Confidential) and Roxane's Objections and Responses to Vanda's Third Set of Interrogatories (Nos. 9-10) (Confidential) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 08/14/2015)

2015-08-14

1

View

NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Roxane's Third Set of Interrogatories (Nos. 9-13); (2) Plaintiffs' Objections and Responses to Roxane's Third Set of Requests for Production (Nos. 55-57) filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 08/14/2015)

2015-08-14

1

View

NOTICE to Take Deposition of Sarah Smith on August 25, 2015 filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 08/14/2015)

2015-08-14

1

View

MOTION for Pro Hac Vice Appearance of Attorney Melissa Brand of Latham & Watkins LLP - filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 08/17/2015)

2015-08-17

1

View

SO ORDERED

2015-08-19

1

No Actions

SO ORDERED - re 120 MOTION for Pro Hac Vice Appearance of Attorney Melissa Brand of Latham & Watkins LLP filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 8/19/2015. (mdb)

2015-08-19

1

No Actions

NOTICE OF SERVICE of (1) Plaintiffs' Objections and Responses to Roxane's Fourth Set of Interrogatories (No. 14); and (2) Vanda's Responses and Objections to Defendant's Notice of Deposition Under Rule 30(b)(6) filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 08/28/2015)

2015-08-28

1

View

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Supplemental Invalidity Contentions filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 08/28/2015)

2015-08-28

1

View

NOTICE to Take Deposition of Mihael H. Polymeropoulos on September 11, 2015 filed by Roxane Laboratories Inc..(Moore, David) (Entered: 08/31/2015)

2015-08-31

1

View

NOTICE OF SERVICE of Third Party Subpoena to Testify upon Curt Wolfgang, Ph.D. filed by Roxane Laboratories Inc..(Moore, David) (Entered: 08/31/2015)

2015-08-31

1

View

Minute Entry for proceedings held before Judge Gregory M. Sleet - Markman Hearing held on 9/2/2015. Claim construction presentations; The Court will take the matter under advisement and issue a ruling in due course. Oral ruling re Motion to Dismiss in C.A. No. 14-757 GMS: Roxane has not met its burden to prove by clear and convincing evidence that the '610 Patent is invalid on its face for failing to cover patent-eligible subject matter under 35 U.S.C. ยง 101. The motion is DENIED (Court Reporter Kevin Maurer.) (mdb) Modified on 9/21/2015 (mdb).

2015-09-02

1

No Actions

Markman Hearing

2015-09-02

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Markman Hearing held on 9/2/2015. Claim construction presentations; The Court will take the matter under advisement and issue a ruling in due course. Oral ruling re Motion to Dismiss in C.A. No. 14-757 GMS: Roxane has not met its burden to prove by clear and convincing evidence that the '610 Patent is invalid on its face for failing to cover patent-eligible subject matter under 35 U.S.C. § 101. The motion is DENIED (Court Reporter Kevin Maurer.) (mdb) Modified on 9/21/2015 (mdb).

2015-09-02

1

No Actions

ORDER CONSTRUING THE TERMS OF U.S. PATENT NO. 8,586,610. Signed by Judge Gregory M. Sleet on 9/9/2015. (mdb) (Entered: 09/09/2015)

2015-09-09

1

View

Official Transcript of Markman Hrg. held on 09 02 15 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/7/2015. Redacted Transcript Deadline set for 10/19/2015. Release of Transcript Restriction set for 12/15/2015. (kjm) (Entered: 09/16/2015)

2015-09-16

1

View

ANSWER to Complaint by Roxane Laboratories Inc..(Moore, David) (Entered: 10/09/2015)

2015-10-09

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 10/09/2015)

2015-10-09

1

View

Joint STIPULATION Regarding Claim 3 and Claim 9 of U.S. Patent No. RE39,198 by Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 10/16/2015)

2015-10-16

1

Download

SO ORDERED

2015-10-16

1

No Actions

SO ORDERED - re 129 Joint Stipulation Regarding Claim 3 and Claim 9 of U.S. Patent No. RE39,198. Ordered by Judge Gregory M. Sleet on 10/16/2015. (mdb)

2015-10-16

1

No Actions

NOTICE OF SERVICE of (1) Expert Report of Dr. Larry J Kricka, (2) Report of Sheldon H. Preskorn, M.D. and (3) Report of Gustavo Alva, M.D, DFAPA filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 10/19/2015)

2015-10-19

1

View

NOTICE OF SERVICE of Opening Expert Report of Dr. Bruce Sargent; Opening Expert Report of Charles E. McCullough, Ph.D.; and Expert Report of Mark J. Ratain, M.D. (Confidential) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 10/20/2015)

2015-10-20

1

View

STIPULATION (Stipulated Schedule Regarding Letter Briefing on Defendant's Request for Full Summary Judgment Briefing) by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 10/26/2015)

2015-10-26

1

View

[SEALED] Letter to The Honorable Gregory M. Sleet from David E. Moore regarding request for leave to file summary judgment motion. (Attachments: # 1 Exhibit 1-5)(Moore, David) (Entered: 10/26/2015)

2015-10-26

1

View

REDACTED VERSION of 133 Letter to The Honorable Gregory M. Sleet from David E. Moore regarding request for leave to file summary judgment motion by Roxane Laboratories Inc.. (Attachments: # 1 Exhibit 1-5)(Moore, David) (Entered: 11/02/2015)

2015-11-02

1

View

SO ORDERED - re 132 Stipulated Schedule Regarding Letter Briefing on Defendant's Request for Full Summary Judgment Briefing. Set/Reset Scheduling Order Deadlines: Opening Letter Brief due by 10/26/2015., Answering Letter Brief due by 11/23/2015., Reply Letter Brief due by 12/2/2015. Signed by Judge Gregory M. Sleet on 11/3/2015. (mdb) (Entered: 11/03/2015)

2015-11-03

1

View

NOTICE OF SERVICE of (1) Gustavo Alva, M.D. & (2) Sheldon H. Preskorn's Objections & Responses to Defendant's Subpoena to Produce Documents, Information, or Object or to Permit Inspection of Premises in a Civil Action filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Jacobs, Karen) (Entered: 11/13/2015)

2015-11-13

1

View

NOTICE OF SERVICE of (1) Rebuttal Report of Bryan L. Roth, M.D., Ph.D., (2) Rebuttal Report of F. Peter Guengerich, Ph.D. and (3) Rebuttal Report of Paul A. Bartlett Ph.D. filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 11/16/2015)

2015-11-16

1

View

NOTICE OF SERVICE of Expert Report of Neil S. Kaye, M.D., DFAPA (Confidential) and Rebuttal Expert Report of Mark J. Ratain, M.D. (Confidential) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 11/17/2015)

2015-11-17

1

View

NOTICE to Take Deposition of Peter Waibel on November 24, 2015 filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 11/20/2015)

2015-11-20

1

View

[SEALED] Letter to The Honorable Gregory M. Sleet from Ethan H. Townsend regarding opposition to Roxane's request for leave to file summary judgment motion - re 133 Letter. (Attachments: # 1 Exhibits A-B)(Townsend, Ethan) (Entered: 11/23/2015)

2015-11-23

1

View

REDACTED VERSION of 140 Letter to The Honorable Gregory M. Sleet from Ethan H. Townsend regarding opposition to Roxane's request for leave to file summary judgment motion - re 133 Letter. (Attachments: # 1 Exhibits A-B) by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibits A-B)(Townsend, Ethan) Modified on 11/24/2015 (mdb). (Entered: 11/23/2015)

2015-11-23

1

View

[SEALED] Letter to The Honorable Gregory M. Sleet from David E. Moore regarding reply Summary Judgment submission - re 133 Letter. (Attachments: # 1 Exhibit 1-2)(Moore, David) (Entered: 12/01/2015)

2015-12-01

1

View

Joint STIPULATION TO EXTEND TIME for the parties to serve their reply expert reports to December 9, 2015 - filed by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 12/07/2015)

2015-12-07

1

View

REDACTED VERSION of 142 Letter to The Honorable Gregory M. Sleet from David E. Moore regarding reply Summary Judgment submission - re 133 Letter by Roxane Laboratories Inc.. (Attachments: # 1 Exhibit 1-2)(Moore, David) (Entered: 12/08/2015)

2015-12-08

1

View

SO ORDERED

2015-12-08

1

No Actions

SO ORDERED - re 143 Joint STIPULATION TO EXTEND TIME for the parties to serve their reply expert reports to December 9, 2015 filed by Vanda Pharmaceuticals Inc., Aventisub LLC. Ordered by Judge Gregory M. Sleet on 12/8/2015. (mdb)

2015-12-08

1

No Actions

NOTICE OF SERVICE of (1) Reply Expert Report of Dr. Larry J Kricka; (2) Reply Report of Gustavo Alva, M.D. DFAPA; and (3) Reply Report of Sheldon H. Preskorn, M.D., filed by Aventisub LLC, Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 12/09/2015)

2015-12-09

1

View

MOTION for Pro Hac Vice Appearance of Attorney Jason L. Meizlish - filed by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 12/10/2015)

2015-12-10

1

View

NOTICE OF SERVICE of Reply Expert Report of Mark J. Ratain, M.D. [Confidential]; Reply Expert Report of Dr. Bruce Sargent; Reply Report of Charles E. McCulloch, Ph.D.; and Reply Expert Report of Neil S. Kaye, M.D., DFAPA [Confidential] filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 12/10/2015)

2015-12-10

1

View

SO ORDERED

2015-12-14

1

No Actions

SO ORDERED - re 146 MOTION for Pro Hac Vice Appearance of Attorney Jason L. Meizlish filed by Vanda Pharmaceuticals Inc., Aventisub LLC. Ordered by Judge Gregory M. Sleet on 12/14/2015. (mdb)

2015-12-14

1

No Actions

Add Attorneys - PHV only

2015-12-18

1

No Actions

Pro Hac Vice Attorney Jason L. Meizlish for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)

2015-12-18

1

No Actions

ORDER - denying 133 Letter Request for Permission to File Summary Judgment Motions. There are disputes of material facts which raise genuine issues for trial. Signed by Judge Gregory M. Sleet on 12/30/2015. (mdb) (Entered: 12/30/2015)

2015-12-30

1

Download

NOTICE of Issuance of Subpoena upon Assurex Health by Roxane Laboratories Inc. (Palapura, Bindu) (Entered: 12/30/2015)

2015-12-30

1

View

NOTICE OF SERVICE of Amended Report of Sheldon H. Preskorn, M.D. filed by Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 01/04/2016)

2016-01-04

1

View

STIPULATION and Order Regarding Expert Discovery by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 01/08/2016)

2016-01-08

1

Download

SO ORDERED

2016-01-11

1

No Actions

SO ORDERED - re 151 Stipulation and Order Regarding Expert Discovery filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 1/11/2016. (mdb)

2016-01-11

1

No Actions

MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown of Latham & Watkins LLP - filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 01/15/2016)

2016-01-15

1

View

SO ORDERED

2016-01-19

1

No Actions

SO ORDERED - re 152 MOTION for Pro Hac Vice Appearance of Attorney Daniel G. Brown of Latham & Watkins LLP filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 1/19/2016. (mdb)

2016-01-19

1

No Actions

NOTICE OF SERVICE of Supplemental Expert Report of Mark J. Ratain, M.D. filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 01/25/2016)

2016-01-25

1

View

[SEALED] Proposed Pretrial Order by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 01/29/2016)

2016-01-29

1

View

NOTICE OF SERVICE of Roxane Laboratories, Inc.'s Notice Pursuant to 35 U.S.C. Section 282 filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 02/01/2016)

2016-02-01

1

View

REDACTED VERSION of 154 Proposed Pretrial Order by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 02/05/2016)

2016-02-05

1

View

MOTION for Pro Hac Vice Appearance of Attorney Damion Jurrens of Latham & Watkins LLP - filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 02/08/2016)

2016-02-08

1

View

MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Klein - filed by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 02/08/2016)

2016-02-08

1

View

ORAL ORDER RESCHEDULING A PRETRIAL TELECONFERENCE: The Pretrial Teleconference previously set for Wednesday, February 17, 2016 at 10:00 AM Eastern Time with Judge Sleet has been RESCHEDULED to Thursday, February 18, 2016 at 2:00 PM Eastern Time. Ordered by Judge Gregory M. Sleet on 2/8/2016. (asw)

2016-02-08

1

No Actions

Oral Order

2016-02-08

1

No Actions

SO ORDERED - re 157 MOTION for Pro Hac Vice Appearance of Attorney Damion Jurrens of Latham & Watkins LLP filed by Roxane Laboratories Inc., 158 MOTION for Pro Hac Vice Appearance of Attorney Daniel J. Klein filed by Vanda Pharmaceuticals Inc., Aventisub LLC. Ordered by Judge Gregory M. Sleet on 2/11/2016. (mdb)

2016-02-11

1

No Actions

SO ORDERED

2016-02-11

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Final Pretrial Conference via telephone held on 2/18/2016. Discussion and rulings on the evidentiary issues outlined in the Proposed Pretrial Order ( 154 ). (Court Reporter Kevin Maurer.) (mdb)

2016-02-18

1

No Actions

Pretrial Conference - Final

2016-02-18

1

No Actions

[SEALED] STIPULATION and [Proposed] Order re 154 Proposed Pretrial Order by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 02/26/2016)

2016-02-26

1

View

Minute Entry for proceedings held before Judge Gregory M. Sleet - Bench Trial Day One held on 2/29/2016. Opening statements; Plaintiffs' case.(Court Reporter Kevin Maurer.) (mdb)

2016-02-29

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Bench Trial Day Two held on 3/1/2016. Plaintiffs' case continued; Plaintiffs rest; Defendant's case. (Court Reporter Kevin Maurer.) (mdb)

2016-03-01

1

No Actions

Bench Trial - Begun

2016-03-01

1

No Actions

SO ORDERED - re 159 Stipulation filed by Vanda Pharmaceuticals Inc., Aventisub LLC. Ordered by Judge Gregory M. Sleet on 3/2/2016. (mdb)

2016-03-02

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Bench Trial Day Three held on 3/2/2016. Defendant's case continued. (Court Reporter Kevin Maurer.) (mdb)

2016-03-02

1

No Actions

Bench Trial - Held

2016-03-02

1

No Actions

SO ORDERED

2016-03-02

1

No Actions

Minute Entry for proceedings held before Judge Gregory M. Sleet - Bench Trial Day Four held on 3/3/2016. Defendant rests; Plaintiffs' rebuttal case. (Court Reporter Kevin Maurer.) (mdb)

2016-03-03

1

No Actions

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals PLC for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 03/04/2016)

2016-03-04

1

View

Minute Entry for proceedings held before Judge Gregory M. Sleet - Bench Trial Day Five completed on 3/4/2016. Plaintiffs' rebuttal case continued; Plaintiffs rest. The Court will take the matter into consideration and issue a ruling in due course. (Court Reporter Kevin Maurer.) (mdb)

2016-03-04

1

No Actions

Bench Trial - Held

2016-03-04

1

No Actions

Bench Trial - Completed

2016-03-04

1

No Actions

REDACTED VERSION of 159 Stipulation by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 03/08/2016)

2016-03-08

1

View

[SEALED] Letter to The Honorable Gregory M. Sleet from Karen Jacobs regarding Vanda's opposition to Trial exhibit 32. (Attachments: # 1 Ex. A)(Jacobs, Karen) (Entered: 03/08/2016)

2016-03-08

1

View

STIPULATION Regarding Defendant's Trial Exhibits 501 and 502 by Roxane Laboratories Inc.. (Attachments: # 1 Exhibit DTX 501A)(Palapura, Bindu) (Entered: 03/10/2016)

2016-03-10

1

View

[SEALED] Letter to The Honorable Gregory M. Sleet from David E. Moore, Esquire regarding response to Vanda's letter brief re Trial exhibit 32 - re 162 Letter. (Moore, David) (Entered: 03/11/2016)

2016-03-11

1

View

SO ORDERED - re 163 Stipulation Regarding Defendant's Trial Exhibits 501 and 502 filed by Roxane Laboratories Inc. Signed by Judge Gregory M. Sleet on 3/14/2016. (mdb) (Entered: 03/15/2016)

2016-03-15

1

View

REDACTED VERSION of 162 Letter by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 03/15/2016)

2016-03-15

1

View

REDACTED VERSION of 164 Letter to The Honorable Gregory M. Sleet from David E. Moore, Esquire regarding response to Vanda's letter brief re Trial exhibit 32 - re 162 Letter by Roxane Laboratories Inc.. (Moore, David) Modified on 3/21/2016 (mdb). (Entered: 03/21/2016)

2016-03-21

1

View

STIPULATION regarding schedule and page limits for post-trial briefs by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 03/25/2016)

2016-03-25

1

View

SO ORDERED - re 168 Stipulation regarding schedule and page limits for post-trial briefs filed by Vanda Pharmaceuticals Inc., Aventisub LLC. Signed by Judge Gregory M. Sleet on 3/29/2016. (mdb) (Entered: 03/29/2016)

2016-03-29

1

Download

Letter to The Honorable Gregory M. Sleet from Ethan H. Townsend regarding the parties enclosed agreed-upon trial exhibit list. (Attachments: # 1 Agreed List of Exhibits Admitted at Trial)(Townsend, Ethan) (Entered: 04/05/2016)

2016-04-05

1

View

Official Transcript of Final Pretrial Conference held on 2/18/2016 before Judge Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 3/14/2016. Redacted Transcript Deadline set for 3/24/2016. Release of Transcript Restriction set for 5/23/2016. (mdb) (Entered: 04/14/2016)

2016-04-11

1

View

Official Transcript of Bench Trial, Day One held on 2/29/2016 before Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 5/5/2016. Redacted Transcript Deadline set for 5/16/2016. Release of Transcript Restriction set for 7/13/2016. (mdb) (Entered: 04/14/2016)

2016-04-14

1

View

Official Transcript of Bench Trial, Day Two held on 3/1/2016 before Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 5/5/2016. Redacted Transcript Deadline set for 5/16/2016. Release of Transcript Restriction set for 7/13/2016. (mdb) (Entered: 04/14/2016)

2016-04-14

1

View

Official Transcript of Bench Trial, Day Three held on 3/2/2016 before Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 5/5/2016. Redacted Transcript Deadline set for 5/16/2016. Release of Transcript Restriction set for 7/13/2016. (mdb) (Entered: 04/14/2016)

2016-04-14

1

View

Official Transcript of Bench Trial, Day Four held on 3/3/2016 before Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 5/5/2016. Redacted Transcript Deadline set for 5/16/2016. Release of Transcript Restriction set for 7/13/2016. (mdb) (Entered: 04/14/2016)

2016-04-14

1

View

Official Transcript of Bench Trial, Day Five held on 3/4/2016 before Judge Sleet. Court Reporter/Transcriber Kevin Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER Redaction Request due 5/5/2016. Redacted Transcript Deadline set for 5/16/2016. Release of Transcript Restriction set for 7/13/2016. (mdb) (Entered: 04/14/2016)

2016-04-14

1

View

NOTICE requesting Clerk to remove Jason L. Meizlish as co-counsel. Reason for request: no longer associated with the case. (Townsend, Ethan) (Entered: 04/18/2016)

2016-04-18

1

View

Proposed Findings of Fact by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Townsend, Ethan) (Entered: 04/18/2016)

2016-04-18

1

Download

[SEALED] Proposed Findings of Fact by Roxane Laboratories Inc.. (Moore, David) (Entered: 04/18/2016)

2016-04-18

1

View

Letter to The Honorable Gregory M. Sleet from Ethan H. Townsend regarding amended trial exhibit list. (Attachments: # 1 Amended Agreed List of Exhibits Admitted at Trial)(Townsend, Ethan) (Entered: 04/19/2016)

2016-04-19

1

View

Letter to The Honorable Gregory M. Sleet from David E. Moore, Esquire regarding disc containing hyperlinked brief - re 179 Proposed Findings of Fact. (Moore, David) (Entered: 04/25/2016)

2016-04-25

1

View

Letter to The Honorable Gregory M. Sleet from Ethan H. Townsend regarding Vanda's Proposed Post-Trial Findings of Fact and Conclusions of Law (D.I. 178) enclosed on two discs. (Townsend, Ethan) (Entered: 04/25/2016)

2016-04-25

1

Download

NOTICE of Withdrawal of Ethan H. Townsend by Aventisub LLC, Vanda Pharmaceuticals Inc. (Jacobs, Karen) (Entered: 05/02/2016)

2016-05-02

1

View

[SEALED] POST TRIAL BRIEF by Aventisub LLC, Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (Entered: 05/18/2016)

2016-05-18

1

View

[SEALED] POST TRIAL BRIEF by Roxane Laboratories Inc.. (Palapura, Bindu) Modified on 5/19/2016 (mdb). (Entered: 05/18/2016)

2016-05-18

1

View

REDACTED VERSION of 179 Proposed Findings of Fact by Roxane Laboratories Inc.. (Moore, David) (Entered: 05/19/2016)

2016-05-19

1

Download

REDACTED VERSION of 185 POST Trial Brief by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 05/19/2016)

2016-05-19

1

Download

REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 179 (mdb)

2016-05-19

1

No Actions

Deficiency re Redacted Documents

2016-05-19

1

No Actions

Letter to The Honorable Gregory M. Sleet from Karen Jacobs regarding sending two disks containing electronic versions of Vanda's Sealed Post-Trial Reply Brief (D.I. 184) with hyperlinks to exhibits, transcripts, cases and statutes - re 169 SO ORDERED, Set Deadlines, 184 POST Trial Brief. (Jacobs, Karen) (Entered: 05/25/2016)

2016-05-25

1

View

Letter to The Honorable Gregory M. Sleet from David E. Moore regarding disc containing hyperlinked brief - re 185 POST Trial Brief. (Moore, David) (Entered: 05/25/2016)

2016-05-25

1

View

REDACTED VERSION of 184 POST Trial Brief by Aventisub II Inc., Aventisub LLC, Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (Entered: 05/25/2016)

2016-05-25

1

Download

NOTICE requesting Clerk to remove Damion Jurrens as co-counsel. Reason for request: no longer with the firm of Latham & Watkins LLP. (Palapura, Bindu) (Entered: 06/22/2016)

2016-06-22

1

View

NOTICE of Vanda Pharmaceuticals' Notice of Subsequent Authority in Support of Vanda's Proposed Post-Trial Findings of Fact and Conclusions of Law by Aventisub LLC, Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 07/07/2016)

2016-07-07

1

View

NOTICE of Vanda Pharmaceuticals' Notice of Subsequent Authority in Support of Vanda's Proposed Post-Trial Findings of Fact and Conclusions of Law by Aventisub LLC, Vanda Pharmaceuticals Inc. (Attachments: # 1 Exhibit A)(Jacobs, Karen) (Entered: 07/07/2016)

2016-07-07

2

View

MEMORANDUM. Signed by Judge Gregory M. Sleet on 8/25/2016. (mdb)

2016-08-25

1

Download

ORDER re 193 Memorandum - Roxane's ANDA Product infringes claim 3 of the '198 Patent. Roxane's ANDA Product infringes clalins 1-9, 11-13, and 16 of the '610 Patent, except with respect to the Plaintiffs' claim of contributory infringement. Claim 3 of the '198 Patent is not invalid as obvious. Claims 1-9, 11-13, and 16 of the '610 Patent are not invalid as obvious. Claims 1-9, 11-13, and 16 of the '610 Patent are not invalid for lack of written description. Claim 1-9, 11-13, and 16 of the '610 Patent are not invalid for failure to claim patentable subject matter. Pursuant to the court's equitable power, Roxane is hereby enjoined from engaging in the commercial manufacture, use, offer to sell, or sale with the United States, or importation into the United States of Roxane's ANDA Product prior to the expiration of the '610 Patent (November 2, 2027) or any applicable exclusivities and extensions. The effective date of any Food and Drug Administration approval of Roxane's ANDA No. 20-5480 shall be a date not earlier than the latest of the expiration of the '610 Patent or any applicable exclusivities and extensions. The Clerk of Court is directed to enter final judgment in favor of the plaintiffs. The parties' Rule 52(c) motions are granted-in-part and denied-in-part. Signed by Judge Gregory M. Sleet on 8/25/2016. (mdb) (Entered: 08/25/2016)

2016-08-25

1

View

JUDGMENT entered in favor of the plaintiffs and against the defendant (see attached) (CASE CLOSED). Signed by Judge Gregory M. Sleet on 8/25/2016. Associated Cases: 1:13-cv-01973-GMS, 1:14-cv-00757-GMS(mdb) (Entered: 08/25/2016)

2016-08-25

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Memorandum, # 2 Order, # 3 Judgment)(mdb) (Entered: 08/26/2016)

2016-08-26

1

View

CORRECTING ENTRY: The Notice of Service (formerly DI 196) has been removed from the docket. (mdb)

2016-08-26

1

No Actions

- CORRECTING ENTRY

2016-08-26

1

No Actions

NOTICE OF APPEAL to the Federal Circuit of 195 Judgment . Appeal filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 09/23/2016)

2016-09-23

1

View

APPEAL - Credit Card Payment of $505.00 received re 197 Notice of Appeal (Federal Circuit) filed by Roxane Laboratories Inc.. ( Filing fee $505, receipt number 0311-2001663.) (Moore, David)

2016-09-23

1

No Actions

- APPEAL - Credit Card Payment (Attorneys Only)

2016-09-23

1

No Actions

NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit re 197 Notice of Appeal (Federal Circuit) filed by Roxane Laboratories Inc. USCA Case Number 16-2707 (mdb) (Entered: 09/26/2016)

2016-09-26

1

View

Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit re 197 Notice of Appeal (Federal Circuit). (cna)

2016-09-26

1

No Actions

Notification regarding 197 Notice of Appeal (Federal Circuit) sent to Reporter Maurer. (cna)

2016-09-26

1

No Actions

USCA Notice of Appeal and Docket Transmitted

2016-09-26

1

No Actions

USCA Appeal Record Sent to Reporter Maurer

2016-09-26

1

No Actions

NOTICE requesting Clerk to remove Emily C. Melvin as co-counsel. Reason for request: no longer with the firm of Latham & Watkins LLP. (Palapura, Bindu) (Entered: 04/17/2017)

2017-04-17

1

View

OPINION and Judgment of USCA as to 197 Notice of Appeal (Federal Circuit) filed by Roxane Laboratories Inc.. Decision of USCA: USDC Opinion Affirmed (Precedential Opinion). (mdb) Modified on 4/16/2018 (mdb). (Entered: 04/13/2018)

2018-04-13

1

View

ORDER of USCA as to 197 Notice of Appeal (Federal Circuit) filed by Roxane Laboratories Inc.. Decision of USCA: Petitions for panel rehearing and rehearing en banc are denied. The mandate will issue on 8/21/2018.. (mdb) (Entered: 08/20/2018)

2018-08-14

1

View

MANDATE of USCA as to 197 Notice of Appeal (Federal Circuit) filed by Roxane Laboratories Inc.. USCA Decision: USDC decision affirmed. (mdb) (Entered: 08/21/2018)

2018-08-21

1

View

Overview

Parties

Plaintiff

Aventisub LLC Follow

Represented By

Aventisub II Inc. Follow

Represented By

Novartis Pharma AG Follow

Represented By

Defendant

Roxane Laboratories Inc. Follow

Represented By

Novartis Pharmaceuticals Corporation Follow

Represented By

Counter Defendant

Vanda Pharmaceuticals Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 11/26/2013)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/17/13. Date of Expiration of Patent: 11/15/16.Thirty Month Stay Deadline: 11/9/2016. (cla, ) (Entered: 11/26/2013)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE 39,198E;. (cla, ) (Entered: 11/26/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharmaceuticals Corporation identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation. (cla, ) (Entered: 11/26/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Novartis Pharma AG identifying Corporate Parent Novartis AG for Novartis Pharma AG. (cla, ) (Entered: 11/26/2013)

Disclosure Statement pursuant to Rule 7.1 filed by Aventisub II Inc. identifying Other Affiliate Sanofi for Aventisub II Inc.. (cla, ) (Entered: 11/26/2013)

Summons Issued with Magistrate Consent Notice attached as to Roxane Laboratories Inc. on 11/26/2013. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (cla, )

Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. (rjb)

DECLARATION of Mailing (as to service on Defendant Roxane Laboratories, Inc.) by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 12/02/2013)

STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to January 3, 2014 - filed by Roxane Laboratories Inc.. (Horwitz, Richard) (Entered: 12/18/2013)

SO ORDERED, re 9 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to January 3, 2014 filed by Roxane Laboratories Inc. Set/Reset Answer Deadlines: Roxane Laboratories Inc. answer due 1/3/2014. Signed by Chief Judge Gregory M. Sleet on 12/18/13. (mmm)

ANSWER to 1 Complaint,, COUNTERCLAIM against Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation by Roxane Laboratories Inc..(Moore, David) (Entered: 12/20/2013)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Boehringer Ingelheim Corporation for Roxane Laboratories Inc. filed by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 12/20/2013)

ANSWER to 10 Answer to Complaint, Counterclaim Plaintiffs' Reply to Defendants' Counterclaim by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 01/10/2014)

MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Emily C. Melvin, and Michael R. Seringhaus of Latham & Watkins LLP - filed by Roxane Laboratories Inc.. (Moore, David) (Entered: 02/11/2014)

SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Emily C. Melvin, and Michael R. Seringhaus of Latham & Watkins LLP filed by Roxane Laboratories Inc. Ordered by Chief Judge Gregory M. Sleet on 2/11/14. (mmm)

MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Pro Hac Certification for Nicholas N. Kallas)(Silver, Daniel) (Entered: 02/12/2014)

Pro Hac Vice Attorney Emily C. Melvin,Kenneth G. Schuler,Michael R. Seringhaus for Roxane Laboratories Inc. added for electronic noticing. (dmp, )

SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Nicholas N. Kallas filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Chief Judge Gregory M. Sleet on 2/18/2014. (asw)

Pro Hac Vice Attorney Nicholas Kallas for Novartis Pharmaceuticals Corporation added for electronic noticing. (dmp, )

Joint STATUS REPORT by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 03/25/2014)

PROPOSED ORDER Proposed Scheduling Order re 15 Status Report by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 03/25/2014)

Joint PROPOSED ORDER (Proposed Scheduling Order) by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/07/2014)

ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 5/5/2014 at 10:00 AM EASTERN TIME before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 4/10/14. (cak) (Entered: 04/10/2014)

CASE REFERRED to Judge Thynge for Mediation. (cak)

NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 04/21/2014)

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Roxane Laboratories Inc..(Horwitz, Richard) (Entered: 04/21/2014)

Joint STIPULATION TO EXTEND TIME for Plaintiffs to File the Joint Proposed Protective Order to Monday, May 5, 2014 (from Monday, April 21, 2014) - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 04/21/2014)

Joint MOTION for Protective Order [Proposed] Stipulated Protective Order - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 05/05/2014)

SO ORDERED, re 23 Joint MOTION for Protective Order [Proposed] Stipulated Protective Order filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Chief Judge Gregory M. Sleet on 5/6/2014. (asw)

NOTICE of CHANGE OF FIRM ADDRESS by Roxane Laboratories Inc. (Moore, David) (Entered: 05/12/2014)

NOTICE OF SERVICE of Plaintiffs' Disclosures Pursuant to Delaware Default Standard Paragraphs 3 and 5 filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 05/16/2014)

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Disclosures Pursuant to Delaware Default Standard for Discovery filed by Roxane Laboratories Inc..(Horwitz, Richard) (Entered: 05/16/2014)

NOTICE OF SERVICE of Roxane's First Set of Requests for Production of Documents and Things to Plaintiffs (Nos. 1-73) filed by Roxane Laboratories Inc..(Struble, Erich) (Entered: 06/04/2014)

NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests to Roxane for the Production of Documents and Things; and (2) Plaintiffs' First Set of Interrogatories to Roxane filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/05/2014)

NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions to Roxane filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 06/09/2014)

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Amended Disclosures Pursuant to Delaware Default Standard for Discovery filed by Roxane Laboratories Inc..(Struble, Erich) (Entered: 06/13/2014)

NOTICE OF SERVICE of Defendant Roxane Laboratories, Inc.'s Initial Invalidity Contentions filed by Roxane Laboratories Inc..(Horwitz, Richard) (Entered: 07/03/2014)

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Roxane's First Set of Requests for Production filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 07/10/2014)

NOTICE OF SERVICE of Roxane's First Set of Interrogatories to Plaintiffs (Nos. 1-6) filed by Roxane Laboratories Inc..(Palapura, Bindu) (Entered: 08/13/2014)

MOTION for Pro Hac Vice Appearance of Attorney Christina Schwarz - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Certification of Christina Schwarz)(Silver, Daniel) (Entered: 08/28/2014)

SO ORDERED, re 36 MOTION for Pro Hac Vice Appearance of Attorney Christina Schwarz filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. Ordered by Judge Gregory M. Sleet on 8/28/2014. (asw)

Pro Hac Vice Attorney Christina Schwarz for Novartis Pharmaceuticals Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (els)

NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Roxane's First Set of Interrogatories (Nos. 1-6) filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation.(Silver, Daniel) (Entered: 09/15/2014)

MOTION for Pro Hac Vice Appearance of Attorney Timothy J. O'Brien - filed by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 10/03/2014)

SO ORDERED, re 39 MOTION for Pro Hac Vice Appearance of Attorney Timothy J. O'Brien filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 10/6/2014. (asw)

Pro Hac Vice Attorney Timothy J. O'Brien for Roxane Laboratories Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )

STIPULATION and [Proposed] Order Amending Case Scheduling Order to Remove Claim Construction Deadlines and Hearing by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 10/16/2014)

SO ORDERED - re 40 Stipulation. The claim construction deadlines are terminated and the Markman Hearing set for 3/31/2015 at 9:30 AM is CANCELED. Signed by Judge Gregory M. Sleet on 10/17/2014. (mdb) (Entered: 10/17/2014)

(WITHDRAWN) MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Roxane Laboratories Inc.. (Palapura, Bindu) Modified on 10/31/2014 (mdb). (Entered: 10/21/2014)

NOTICE of Withdrawal of Defendant's Motion to Dismiss and Supporting Brief by Roxane Laboratories Inc. re 42 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter, 43 Opening Brief in Support, (Palapura, Bindu) (Entered: 10/30/2014)

MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 10/30/2014)

OPENING BRIEF in Support re 45 MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter filed by Roxane Laboratories Inc..Answering Brief/Response due date per Local Rules is 11/17/2014. (Attachments: # 1 Exhibit A-B)(Palapura, Bindu) (Entered: 10/30/2014)

MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION - filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Text of Proposed Order)(Silver, Daniel) (Entered: 11/17/2014)

DECLARATION re 48 Brief (Combined Opening and Answering),, Declaration of Andrea Q. Ryan by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Attachments: # 1 Appendix A - E)(Silver, Daniel) (Entered: 11/17/2014)

STATEMENT re 47 MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION Rule 7.1.1 Certification by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 11/18/2014)

STIPULATION to Extend Certain Briefing Deadlines by Roxane Laboratories Inc.. (Palapura, Bindu) (Entered: 11/20/2014)

SO ORDERED - re 51 Stipulation to Extend Certain Briefing Deadlines filed by Roxane Laboratories Inc. Ordered by Judge Gregory M. Sleet on 11/25/2014. (mdb)

REPLY BRIEF re 47 MOTION to Amend/Correct PLAINTIFFS' MOTION UNDER FED. R. CIV.P. 25(c) TO AMEND THE CAPTION filed by Aventisub II Inc., Novartis Pharma AG, Novartis Pharmaceuticals Corporation. (Silver, Daniel) (Entered: 01/09/2015)

Aventisub LLC

Aventisub II Inc.

Novartis Pharma AG

Roxane Laboratories Inc.

Novartis Pharmaceuticals Corporation

Vanda Pharmaceuticals Inc.